ARIEL LINEHAN: Open Payments
NPI 1942740592 · CANTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $717 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $199 |
| Organon LLC | 2 | $67 |
| Incyte Corporation | 2 | $56 |
| Amgen Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $26 |
| UCB, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
Products named: SKYRIZI, OPZELURA, Otezla, TREMFYA, HADLIMA, RINVOQ, DUPIXENT, ILUMYA.
Industry payments across MA — which companies pay providers there.
